Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Peloton Equity AeroCare SPV I, L.P.	2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 66 FIELD POINT ROAD, 2ND FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 5/15/2023
(Street) GREENWICH, CT 06830	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person
(City) (State) (Zip)	Rule 10b5-1(c) Transaction Indication ☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	5/15/2023		J⁽¹⁾		2220278	D	⁽¹⁾	4460555	D ⁽²⁾
Common Stock	5/15/2023		J⁽¹⁾		211449	D	⁽¹⁾	422898	I	By Peloton Equity AeroCare SPV II, L.P. ⁽³⁾
Common Stock	5/15/2023		J⁽¹⁾		714054	D	⁽¹⁾	1428109	I	By Peloton Equity I, L.P. ⁽⁴⁾
Common Stock								675832 ⁽⁵⁾	I	By Peloton Equity GP, LLC ⁽⁵⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
(1)	On May 15, 2023, each of Peloton AeroCare SPV I, L.P. ("Peloton AeroCare I"), Peloton AeroCare SPV II, L.P. ("Peloton AeroCare II") and Peloton Equity I, L.P. ("Peloton Equity I") distributed to their limited partners, pro rata and without consideration, 2,220,278 shares, 211,449 shares and 714,054 shares, respectively, of Common Stock. The aforementioned distributions were made in accordance with the exemptions afforded under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
(2)	Shares held by Peloton AeroCare I. Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
(3)	Shares held by Peloton AeroCare II. Peloton Equity GP is the general partner of Peloton AeroCare II. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
(4)	Shares held by Peloton Equity I. Peloton Equity GP is the general partner of Peloton Equity I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
(5)	Shares held by Peloton Equity GP. Includes 675,832 shares of Common Stock received in the distributions described herein made in accordance with the exemptions afforded under Rule 16a-9(a) and Rule 16a-13 of the Exchange Act. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Remarks:
Theodore B. Lundberg, a managing member of Peloton Equity GP, has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Lundberg's representation, for purposes of Section 16 of the Exchange Act, each of the Reporting Persons may be deemed directors by deputization of the Issuer. Mr. Lundberg has filed a separate Section 16 report disclosing securities of the Issuer that he may be deemed to beneficially own for Section 16 purposes. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Peloton Equity AeroCare SPV I, L.P. 66 FIELD POINT ROAD, 2ND FLOOR GREENWICH, CT 06830	X
Peloton Equity AeroCare SPV II, L.P. 66 FIELD POINT ROAD, 2ND FLOOR GREENWICH, CT 06830	X
Peloton Equity I, L.P. 66 FIELD POINT ROAD, 2ND FLOOR GREENWICH, CT 06830	X
Peloton Equity GP, LLC 66 FIELD POINT ROAD, 2ND FLOOR GREENWICH, CT 06830	X
FERRER CARLOS A 66 FIELD POINT ROAD, 2ND FLOOR GREENWICH, CT 06830	X

Signatures
Peloton Equity AeroCare SPV I, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member		5/16/2023
^**Signature of Reporting Person		Date
Peloton Equity AeroCare SPV II, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member		5/16/2023
^**Signature of Reporting Person		Date
Peloton Equity I, L.P., By: Peloton Equity GP, LLC, its general partner By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member		5/16/2023
^**Signature of Reporting Person		Date
Peloton Equity GP, LLC, By: /s/ Theodore B. Lundberg, Name: Theodore B. Lundberg, Title: Managing Member		5/16/2023
^**Signature of Reporting Person		Date
Carlos Ferrer, by: /s/ Carlos Ferrer		5/16/2023
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.